Biofrontera (BFRIW) Receivables - Net (2020 - 2025)

Biofrontera's Receivables - Net history runs 6 years deep, the most recent figure standing at $7.3 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 37.18% year-over-year to $7.3 million; the TTM figure through Dec 2025 stood at $7.3 million (up 37.18% YoY), while the FY2025 annual figure was $7.3 million, up 37.18% from the prior year.
• Receivables - Net was $7.3 million for Q4 2025 at Biofrontera, up from $3.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $7.3 million in Q4 2025 to a low of $1.6 million in Q3 2022.
• Historically, Receivables - Net has averaged $3.8 million across 5 years, with a median of $3.8 million in 2021.
• The sharpest annual moves came in 2023 and 2025: Receivables - Net surged 142.83% in 2023, then tumbled 38.55% in 2025.
• A 5-year view of Receivables - Net shows it stood at $3.8 million in 2021, then declined by 0.95% to $3.7 million in 2022, then surged by 37.73% to $5.2 million in 2023, then grew by 2.96% to $5.3 million in 2024, then jumped by 37.18% to $7.3 million in 2025.
• The last three Receivables - Net figures came in at $7.3 million (Q4 2025), $3.0 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.